Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
A SPAC I Acquisition Unit | ASCAU | Apr 30, 2024 | 2.96 | 0.00 |
A SPAC II Acquisition | ASCB | Apr 30, 2024 | 11.09 | -0.44 |
A-Mark Precious Metals | AMRK | Apr 30, 2024 | 40.07 | -2.39 |
a.k.a Brands | AKA | Apr 30, 2024 | 14.51 | +9.51 |
A.O Smith | AOS | Apr 30, 2024 | 82.84 | -1.74 |
A10 Networks | ATEN | Apr 30, 2024 | 13.06 | -2.54 |
A2Z Smart Technologies | AZ | Apr 30, 2024 | 0.41 | -3.40 |
AAA - A Rated Corporate Bond Ishares | QLTA | Apr 30, 2024 | 46.08 | -0.45 |
Aadi Bioscience | AADI | Apr 30, 2024 | 1.92 | +3.23 |
AAON | AAON | Apr 30, 2024 | 94.09 | +0.26 |
AAR | AIR | Apr 30, 2024 | 69.14 | -0.10 |
Abacus Life | ABL | Apr 30, 2024 | 11.96 | +1.01 |
Abbott Laboratories | ABT | Apr 30, 2024 | 105.97 | -1.21 |
AbbVie | ABBV | Apr 30, 2024 | 162.64 | +0.69 |
AbCellera Biologics | ABCL | Apr 30, 2024 | 3.78 | -1.56 |
Abeona Therapeutics | ABEO | Apr 30, 2024 | 4.14 | +20.35 |
Abercrombie & Fitch | ANF | Apr 30, 2024 | 121.52 | -3.09 |
Aberdeen Asia-Pacificome Fund | FAX | Apr 30, 2024 | 2.50 | -0.79 |
Aberdeen Australia Equity Fund | IAF | Apr 30, 2024 | 4.20 | -1.98 |
Aberdeen Emerging Markets Fund | AEF | Apr 30, 2024 | 5.02 | -1.18 |
Aberdeen Global Fund | FCO | Apr 30, 2024 | 5.47 | -1.44 |
Aberdeen Global Infrastructure | ASGI | Apr 30, 2024 | 17.19 | -0.87 |
Aberdeen Income Credit Strategies Fund | ACP | Apr 30, 2024 | 6.54 | +0.31 |
Aberdeen Income Credit Strategies Pref | ACP-A | Apr 30, 2024 | 23.36 | 0.00 |
Aberdeen Japan Equity Fund | JEQ | Apr 30, 2024 | 5.86 | -0.85 |
Abits Group | ABTS | Apr 30, 2024 | 0.77 | -2.48 |
Abivax SA - American Depositary Shares | ABVX | Apr 30, 2024 | 15.00 | -3.35 |
Able View Global | ABLV | Apr 30, 2024 | 1.37 | -3.52 |
ABM Industries | ABM | Apr 30, 2024 | 43.70 | -1.29 |
Abrdn Global Dynamic Dividend Fund | AGD | Apr 30, 2024 | 9.31 | -1.48 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.